Eribulin Baxter

Medicinal product

(Invented) name

Eribulin Baxter

Active substance (s)

Eribulinas

Strength

0,44 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XX41, Eribulin

Marketing authorisation holder

Baxter Holding B.V. , Nyderlandai

Date of authorisation

2024-06-27

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Viename mililitre yra	1 ml
Eribulinas	0,44 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113991	100107	1100107	flakonas	2 ml N1		Receptinis	EU/1/24/1819/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-06-27	Registruotas